Kai Zhao
Changsha, 410000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Author Correction: STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation.
Journal: Experimental & molecular medicine
Published: September 28, 2024
STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation.
Journal: Experimental & molecular medicine
Published: December 15, 2023
Acetylation is required for full activation of the NLRP3 inflammasome.
Journal: Nature communications
Published: April 04, 2023
Leukadherin-1 inhibits NLRP3 inflammasome by blocking inflammasome assembly.
Journal: International immunopharmacology
Published: December 05, 2022
NLRP3 inflammasome contributes to endotoxin-induced coagulation.
Journal: Thrombosis research
Published: November 29, 2021
YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3.
Journal: Nature communications
Published: May 31, 2020
Acetylase inhibitor SI-2 is a potent anti-inflammatory agent by inhibiting NLRP3 inflammasome activation.
Journal: International immunopharmacology
Published: March 23, 2020
β-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC.
Journal: Molecular immunology
Published: November 08, 2019
The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Journal: The Journal of biological chemistry
Published: November 01, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026